MOTS-c
A mitochondrial-encoded 'exercise mimetic' peptide with strong lab-bench interest but very little human data yet.
What is MOTS-c?
MOTS-c is a mitochondrial-derived peptide, meaning it is encoded by your mitochondrial DNA rather than the DNA in the cell nucleus. Discovered in 2015, it helped establish that mitochondria act as signaling organelles, not just power plants. It is studied mainly for metabolism and as an exercise-mimetic, and its natural levels rise with exercise and decline with age. It is investigational, with the evidence still mostly in animals.
How MOTS-c works
MOTS-c acts on core metabolic pathways, most notably AMPK, a master energy sensor. Through that route it influences glucose uptake, lipid metabolism, and insulin sensitivity, and under stress it can move to the cell nucleus and adjust gene expression. This is why it is described as reproducing some of the metabolic effects of exercise. The signaling is well mapped in preclinical models.
What the research shows
In animal studies MOTS-c improves insulin sensitivity and metabolic flexibility, and in one line of work it added to the benefit of exercise training rather than simply replacing it. Its decline with age has made it a longevity-research target. The honest boundary is that this is largely animal and cell data. Human clinical trials of injected MOTS-c are minimal, so the metabolic and anti-aging benefits people hope for are not yet demonstrated in people.
Dosage and how it is used
There is no clinically validated dose. Community protocols use subcutaneous injection, but the numbers come from animal extrapolation rather than human dose-finding studies. Because the human evidence is thin, any protocol should be read as unproven.
→ How to reconstitute MOTS-c: calculator, units to draw & storage
Side effects and safety
There is minimal human safety data for injected MOTS-c. Short-term animal studies have not flagged major toxicity, but that is a low bar and does not establish a human safety profile. As with other research peptides, unregulated sourcing adds purity uncertainty.
- Research depth: strong preclinical metabolic biology; minimal human data.
- No established human dose or safety profile; injected-use evidence is animal-level.
- Not FDA-approved. Verify current legal and regulatory status independently.
Frequently asked questions
What does MOTS-c do?
In animal and cell studies it activates AMPK, improves insulin sensitivity and glucose handling, and behaves like an exercise mimetic. Its natural levels rise with exercise and fall with age. Most of this is preclinical, so the human benefit is not established.
Is MOTS-c proven in humans?
No. The metabolic biology is compelling in animals, but there is minimal human clinical data on injected MOTS-c, and no approved therapeutic use. Treat it as a promising research peptide, not a validated treatment.
Is MOTS-c really an exercise mimetic?
In rodents it reproduces several metabolic effects of exercise and adds to the benefit of actual training. Calling it an exercise mimetic is a fair description of the animal data, but it does not mean it replaces exercise in people.
Is MOTS-c FDA-approved?
No. It is an investigational mitochondrial-derived peptide, sold as a research compound, with legal status that varies by jurisdiction.
References
Track MOTS-c in Peptide AI
Log your doses, connect labs and wearables, and let the AI show you how MOTS-c is affecting your biomarkers over time.
Download the appEducational information only. This is not medical advice. Peptide AI is an informational and tracking platform. Everything on this page is for general education. It is not a substitute for professional medical advice and is not a recommendation to use any compound. Many peptides listed here are research compounds the FDA has not approved for human use. Talk to a qualified, licensed healthcare provider before you start, change, or stop any protocol.